Isis Innovation LTD
This article was originally published in Start Up
Oxford University's technology transfer group, Isis Innovation, has been around for thirteen years. But it's only since 1997 that the show has really begun.
You may also be interested in...
Nucleic acid-based therapies are poised to revolutionize medicine – just as antibodies did thirty years ago.
Oncology dominates pharma sales and pipeline league tables. But where is the next Keytruda?
Mid-sized M&A, collaborations, creative financing, and biotech consolidation will feature in 2023. IPOs and follow-ons play bit-parts.